<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20">
 <label>20</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tadesse</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mekonnen</surname>
    <given-names>L. B.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Highly potent, selective, and orally bioavailable 4-thiazol-
   <italic>N</italic>-(pyridin-2-yl)pyrimidin-2-amine cyclin-dependent kinases 4 and 6 inhibitors as anticancer drug candidates: design, synthesis, and evaluation
  </article-title>
  <source>
   <italic toggle="yes">Journal of Medicinal Chemistry</italic>
  </source>
  <year>2017</year>
  <volume>60</volume>
  <issue>5</issue>
  <fpage>1892</fpage>
  <lpage>1915</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b01670</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85015022315</pub-id>
  <pub-id pub-id-type="pmid">28156111</pub-id>
 </element-citation>
</ref>
